ABSTRACT
L assa fever is a public health threat in West Africa. There are 300,000 to 500,000 cases annually and 5,000 to 6,000 deaths (1) . The transmission of Lassa virus (LASV), the etiologic agent, to humans can cause a wide variety of symptoms ranging from an asymptomatic infection to a fatal severe hemorrhagic fever in up to 15% of cases. The antiviral drug ribavirin is effective, but there are issues associated with its use, particularly, cost, the need for early administration, and the deleterious effects observed during pregnancy. A safe and effective vaccine is urgently needed, and several vaccine candidates have been studied (2) . However, no useful vaccine is commercially available and approved.
Lassa virus is a bisegmented, negative, single-stranded RNA (ssRNA) virus belonging to the Old World Arenavirus family (3) . The viral genome encodes four genes in an ambisense manner. The small (S) segment encodes the precursor of the glycoprotein (GPC, cleaved to give GP1 and GP2) and the nucleoprotein (NP). The RNA-dependent RNA polymerase L and the small zinc finger matrix Z protein are encoded by the large (L) segment. NP is a multifunctional protein involved in viral genomic RNA encapsidation, viral RNA synthesis, and, by inhibiting the type I interferon (IFN) pathway, immune evasion (4) (5) (6) . NP has a 3=-5= exonuclease activity comparable to the DEDDh enzymes so that it can process double-stranded RNA (dsRNA) substrates (7) (8) (9) . The degradation of immunostimulatory dsRNA molecules prevents RIG-I (retinoic acid-inducible gene I) recognition and downstream initiation of type I IFN production (7, 10) .
LASV replicates in antigen-presenting cells (APC), including dendritic cells (DC) and macrophages (M), without causing cytopathic effects (11, 12) . Upon infection, DC remain unactivated, and M produce only very small amounts of type I IFN (13) . Low and late T cell responses without cytotoxicity or memory occur during LASV infection of DC in an in vitro model (14) . Similarly, we have shown that LASV-infected DC do not induce NK cell activation in vitro (15) . LASV infection of M leads to the activation of NK cells, the downregulation of the chemokine receptor CXCR3, the upregulation of the cytotoxicity receptor NKp30, and an increased ability to kill sensitive K562 targets. The activation mediated by LASV-infected M, however, is not sufficient to enable the killing of infected cells or the production of IFN-␥. We also found that NK cell activation requires type I IFN although only small amounts are produced.
NK cell functions during viral infections have been extensively studied (16) . NK cells are involved in viral clearance by killing infected cells and in the initiation of T cell responses promoted by IFN-␥ production (17) . The cross talk with APC potentiates NK cell functions: receptor/ligand signaling during contacts between cells and with soluble mediators such as type I IFN are essential for the activation of NK cell cytotoxicity and trigger NK cell-mediated production of IFN-␥ (18) .
We have generated a recombinant LASV containing D389A and G392A substitutions in the C-terminal domain of NP (rNP-LASV). D389 was previously shown to be involved in the exonuclease activity of NP as it is within the active site, and G392 was found to be crucial for IFN suppression (4, 7, 8) . rNP-LASV, but not the recombinant wild-type virus (rWT-LASV), induces substantial production of type I IFN by DC and M (19) . We show here that DC and M infected by rNP-LASV induce strong NK cell activation leading to IFN-␥ secretion. The stimulated NK cells trigger cytotoxicity toward infected cells and activation of APC. This work shows for the first time that the exonuclease function of LASV NP is involved in the inhibition of APC functions, including mediating NK cell activation. NK cells are central to the initiation of T cell responses, so these findings contribute insights that will help in the design of vaccines that elicit long-lasting T cell immunity.
MATERIALS AND METHODS
Cells and virus strains. Vero E6 and K562 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 1% penicillinstreptomycin and with 5% and 10% fetal calf serum (FCS), respectively (all from Life Technologies, Saint Aubin, France), at 37°C with 5% CO 2 .
Recombinant wild-type LASV (rWT-LASV) and NP-D389A/G392A (rNP-LASV) were generated by reverse genetics as previously described (19) and passaged twice in Vero E6 cells. Viral supernatants were harvested, titrated, and used as the infectious virus stock. Virus-free supernatants of Vero E6 cell cultures were used for mock experiments.
Cell lines and virus stocks were not contaminated by mycoplasma. All experiments were carried out in biosafety level 4 (BSL4) facilities (Laboratoire P4 Jean Mérieux-Inserm, Lyon, France).
Preparation of DC, M, and NK cells. Monocytes and NK cells were isolated from the blood of consenting healthy donors provided by the Etablissement Français du Sang (Lyon, France) as previously described (11, 15) . In particular, monocytes and NK cells were purified by immunomagnetic depletion and negative selection with a monocyte isolation kit and an NK cell isolation kit, respectively (both from Miltenyi Biotech, Auburn, CA, USA).
Monocytes were then induced to differentiate into M and DC by culture in RPMI 1640 medium with GlutaMAX I, 1% penicillin-streptomycin, 10 mM HEPES, 1% nonessential amino acids, and 10% FCS (all from Life Technologies) (C-RPMI), supplemented with 50 ng/ml macrophage colony-stimulating factor (M-CSF; Miltenyi Biotech) and 10% autologous decomplemented plasma for M or with 1,000 IU/ml granulocyte-macrophage colony-stimulating factor (GM-CSF) and 500 IU/ml interleukin-4 (IL-4) (all from PeproTech, London, United Kingdom) for DC; 40% of the medium and cytokines was replaced every 48 h, and DC and M were harvested after 6 days.
NK cells were frozen in 90% FCS-10% dimethyl sulfoxide (DMSO) (Sigma, Saint-Quentin Fallavier, France) and stored in liquid nitrogen until culture with DC or M. Infection of DC and M and culture with NK cells. DC and M were incubated for 1 h at 37°C with virus-free Vero E6 cell supernatant (mock) or recombinant LASV at a multiplicity of infection (MOI) of 2, washed, and resuspended at 10 6 cells/ml in C-RPMI medium. In coculture experiments, NK cells were thawed and added to APC cultures at an NK cell/APC ratio of 1:5. In some experiments, contact between NK cells and APC was prevented by a polycarbonate membrane with 0.4-m pores (Corning Life Sciences, Schiphol-Rijk, The Netherlands).
Phenotypic analysis by flow cytometry. Cells were harvested and incubated with specific monoclonal antibody (MAb) in phosphate-buffered saline (PBS)-5% human serum for 30 min at 4°C. NK cell surface molecules were stained with the following antibodies 
CD56
ϩ phenotype. CD107a assay. NK cell degranulation was assessed by CD107a labeling. Mouse anti-CD107a-FITC Ab (H4A3; BD Pharmingen) was added at 48 h postinfection, and cells were incubated for 4 h at 37°C. Monensin (Golgi-Stop; BD Pharmingen) was used for the last 3 h to prevent CD107a degradation. NK cells were then labeled using Ab specific for phenotypic surface molecules and analyzed by flow cytometry. NK cells were gated as CD56 ϩ CD3 Ϫ CD14 Ϫ cells. In some experiments, K562 target cells were added after 48 h to the NK/APC cultures at an effector/target (E/T) ratio of 10:1 to induce degranulation.
ELISA. Supernatants of cultures were collected at 24 and 72 h postinfection and stored at Ϫ80°C. Commercial enzyme-linked immunosorbent assay (ELISA) kits were used to assay IFN-␥ (Bender MedSystems), soluble UL16-binding protein 1 (sULBP-1), and IL-18 (R&D Systems, Lille, France) according to the manufacturers' instructions.
Analysis of mRNA levels by quantitative reverse transcription-PCR (RT-PCR). Total RNA was obtained at 24 h after infection using RNeasy kits and DNA I digestion (Qiagen, Hilden, Germany). Reverse transcription was carried out using SuperScript III reverse transcriptase, RNaseOUT, first-strand buffer, dithiothreitol (DTT), oligo(dT), and deoxynucleoside triphosphate (dNTP) mix (all from Life Technologies). The resulting cDNA was analyzed by real-time PCR in an ABI Prism 7000 (Applied Biosystems, Foster City, CA, USA) or a LightCycler 480 (Roche Diagnostic, Meylan, France) thermocycler with TaqMan Universal master mix and commercial primers and probes for the sequences encoding IFN-␥, GrzB, perforin, FasL, TRAIL, MICA, MICB, ULBP-1, ULBP-2, B7H6, IL-12p35, IL-12p40, IL-15, and IL-18 (all from Applied Biosystems). The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was amplified with commercial primers and probes (Applied Biosystems) for normalization. Relative mRNA levels were then calculated as 2 Ϫ⌬CT , where C T is cycle threshold and ⌬C T ϭ C T of the target gene Ϫ C T of GAPDH.
Statistical analysis.
Statistical analyses were performed with GraphPad Prism software, version 5.04 (San Diego, CA, USA). One-way analysis of variance (ANOVA) with a Bonferroni post hoc test, Kruskal-Wallis with Dunn's test, and two-way ANOVA followed by a Bonferroni test were used as specified in the figure legends to determine the significance of differences (P Ͻ 0.05).
RESULTS

NK cells are activated by rNP-LASV-infected APC.
As previously shown (19), we observed that in contrast to rWT-LASV, rNP-LASV was strongly attenuated in DC and M single cultures as well as NK/APC cocultures (data not shown). Infection of APC with rNP-LASV leads to the production of large amounts of type I IFN, whereas this is not the case following infection with rWT-LASV (19) . Similarly, the levels of type I IFN produced in NK/APC cocultures were comparable to the level found in APC single cultures (data not shown). We infected DC and M with rWT-LASV, rNP-LASV, or a virus-free supernatant (mock), and NK cells were then added. The cells were incubated for 72 h, and the NK cells were stained for various markers of activation and analyzed by flow cytometry. During rWT-LASV infection, only M were able to induce CD69 expression on NK cells, and the level of CD25 expression remained unchanged (Fig. 1 ). CD69 and CD25 were significantly upregulated on NK cells after stimulation with rNP-LASV-infected DC and M (Fig. 1) . The numbers of CD69-expressing NK cells were higher during rNP-LASV than rWT-LASV infection of M. Thus, the infection of DC and M by a recombinant LASV mutated within or nearby the exonuclease domain of NP leads to strong NK cell activation.
Activating and chemokine NK cell receptors are modulated by rNP-LASV-infected APC. NK cells were stimulated with rWT-LASV-infected, rNP-LASV-infected, or mock-infected DC or M for 72 h, and the expression of selected NK cell receptors was investigated by flow cytometry. We analyzed the expression of NKp30 and NKG2D, which are involved in NK cell-mediated cytotoxicity. NKp30 was significantly upregulated on NK cells cultured with rWT-LASV-infected M only, and the expression of NKG2D was unchanged upon culture with rWT-LASV-infected M (Fig. 1 ). NKp30 expression was not modified during rNP-LASV infection of DC, but it was significantly decreased after stimulation with infected M. rNP-LASV-infected DC and M induced NKG2D downregulation on NK cells. We also studied the expression of the chemokine receptor CXCR3. Upon rWT-LASV infection, CXCR3 was downregulated only after stimulation with infected M (Fig. 1) . In contrast, rNP-LASV-infected DC and M each induced a significant and large decrease in CXCR3 surface expression. Thus, the expression levels of some activating and chemokine NK cell receptors are substantially modified during the infection of APC by a recombinant LASV harboring mutations affecting the exonuclease activity of NP.
NK cell activation mediated by rNP-LASV-infected APC involves cell contacts and soluble factors. We have previously shown that cell contacts as well as soluble factors are involved in NK cell activation mediated by LASV-infected M (15) . Here, we tested whether cell contacts contribute to the activation and the modification of the repertoire of NK cells during rNP-LASV infection. NK cells were cultured for 72 h with rNP-LASV-or mock- Statistical significance of differences was determined using one-way ANOVA, and differences between conditions were assessed by a Bonferroni post hoc test (*, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001; ****, P Ͻ 0.0001).
infected APC either as mixed cultures or separated from them by a semipermeable membrane (transwell culture). NK cells were then stained and analyzed by flow cytometry. Consistent with previous findings, rNP-LASV-infected DC and M induced an increase in CD69 expression by NK cells in mixed cultures (Fig. 2) . When NK cells were separated from the rNP-LASV-infected APC, CD69 was still upregulated but to a lower extent, which was significant for DC cultures, indicating that both cell contacts and soluble factors contribute to CD69 upregulation. In transwell cultures with no cell contacts between NK cells and rNP-LASV-infected APC, the CD25 upregulation observed in mixed cultures was completely absent. We also observed that the modification of the expression of NKG2D but not of CXCR3 was significantly smaller in transwell cultures than in mixed cultures. Thus, NK cell activation and the modification of the expression of some receptors involve cell contacts with infected DC and M as well as APC-produced soluble factors. However, the decline in CXCR3 expression is dependent only on soluble factors.
rNP-LASV-infected M induce the production of IFN-␥ by NK cells. NK cells were cultured with rWT-LASV-, rNP-LASV-, or mock-infected DC or M, and IFN-␥ synthesis was investigated. Total mRNA was extracted and analyzed by real-time RT-PCR; the changes in the abundance of IFN-␥ mRNA in the NK/ APC cultures during rWT-LASV infection were small, whereas there was a substantial and significant increase after stimulation with rNP-LASV-infected DC and M (Fig. 3A) . As expected, we confirmed that low levels of mRNA encoding IFN-␥ were tran- Two-way ANOVA followed by a Bonferroni post hoc test was used for statistical analysis, and significant differences between mix and transwell means are shown (*, P Ͻ 0.05; **, P Ͻ 0.01; ****, P Ͻ 0.0001). scribed in DC and M single cultures (data not shown). Indeed, NK cells are known to be major producers of IFN-␥ along with T cells. Culture supernatants were collected and assayed by ELISA. Large amounts of IFN-␥ were detected only in NK cell and rNP-LASV-infected M cultures (Fig. 3B) . This is the first demonstration that a recombinant LASV carrying mutations that affect the exonuclease function of NP can induce NK cell-mediated IFN-␥ secretion in the presence of infected M.
Granzyme B, perforin, FasL, and TRAIL lytic factors as well as Fas receptor seem to be upregulated during rNP-LASV infection. DC and M were infected with rWT-LASV, rNP-LASV, or with mock supernatant, and NK cells were added to the cultures. We investigated the expression of some molecules involved in cytotoxicity, including granzyme B (GrzB) and perforin, components of lytic granules, and Fas/FasL and TRAIL/TRAIL receptors DR4 and DR5, involved in the death receptor (DR) pathway. The abundance of GrzB mRNA was higher, but not significantly higher, in culture with rNP-LASV-infected M than in controls (Fig. 4A) . Similarly, the amount of intracellular GrzB found by flow cytometry was slightly, but not significantly, larger than that of controls in NK cells cultured with rWT-LASV-infected M only and rNP-LASV-infected APC (Fig. 4B) . Only the amount of mRNA encoding perforin was found to be significantly above control values in the culture of NK cells and rNP-LASV-infected M (Fig. 4A) . However, the amount of intracellular perforin in NK cells in the infected cultures was not different from that in controls (data not shown). FasL mRNA was more abundant in the culture of NK cells and rNP-LASV-infected M than in controls. The amount of TRAIL mRNA was unaffected by rWT-LASV infection but was substantially higher in cultures of NK cells and rNP-LASV-infected DC or M. Soluble FasL and TRAIL concentrations in the supernatant of rNP-LASV-infected NK/APC cultures were below the threshold of detection by ELISA (data not shown).
DC and M were harvested at 72 h postinfection and stained for the Fas receptor. No change was observed during rWT-LASV infection (Fig. 4C) . However, the expression of Fas at the surface of rNP-LASV-infected DC and M was stronger although the difference was significant only for DC cultures. We found no difference in the expression levels of TRAIL receptors DR4 and DR5 (data not shown).
These investigations show that the infection by a recombinant LASV containing mutations affecting the exonuclease activity of NP seems to increase cytotoxic abilities of NK cells, possibly involving GrzB/perforin and Fas/TRAIL death receptor pathways.
rNP-LASV-infected APC stimulate NK cell cytotoxicity. NK cells were cultured with rWT-LASV-, rNP-LASV-, or mock-infected DC or M for 48 h. K562 cells lacking MHC class I were added to the culture for the last 5 h to trigger NK cell-mediated killing. NK cells were then stained, and degranulation was analyzed by CD107a surface exposure. The numbers of CD107a-expressing NK cells increased after dual stimulation with rWT-LASV-infected M and K562 target cells, whereas there was no change with infected DC (Fig. 4D) . NK cell degranulation toward K562 cells was increased after stimulation with rNP-LASV-infected DC and M, but the difference was significant only for DC cultures. Even in the absence of sensitive K562 cells, the expression of CD107a at the surface of NK cells increased upon rNP-LASV infection of DC and M; this indicates that NK cells can themselves trigger degranulation toward infected APC (Fig. 4E ). APC were infected with rNP-LASV at a low MOI to analyze viral growth, and NK cells were added to the cultures. As previously shown (19) , rNP-LASV is strongly attenuated, and the titers were not detectable after 24 to 48 h postinfection (data not shown). Unfortunately, we could not evaluate any difference in rNP-LASV replication in the presence or absence of NK cells. These experiments show that DC and M infected by a recombinant LASV mutated within or nearby the exonuclease domain of NP can increase NK cell cytotoxic functions and stimulate NK cell killing.
rNP-infected DC and M express NK cell-activating NKG2D ligands. DC and M were infected with rWT-LASV, rNP-LASV, or a mock supernatant and cultured with or without NK cells. The expression levels of NKG2D ligands, including MHC class I-related chain A (MICA) and MICB, UL16-binding protein 1 (ULBP-1) and ULBP-2, and B7H6, an NKp30 ligand, were investigated by quantitative RT-PCR and flow cytometry. During rWT-LASV infection, only M seemed to induce MICB transcription (Fig. 5A) . The amounts of the mRNAs for MICA and MICB were modestly higher in the cultures of NK cells and r-NP-LASV-infected DC and M than in controls; the differences were significant only for MICB mRNA in NK/M cultures. We observed similar results in the absence of NK cells (data not shown). MICA/B molecules were significantly overexpressed at the surface of r-NP-LASV-infected DC and M, whereas there was no difference during rWT-LASV infection (Fig. 5B) . The amounts of ULBP-1 and ULBP-2 mRNAs were not modified in the culture of NK cells and rWT-LASV-infected APC (Fig. 5A) . However, there were significantly more ULBP-1 and ULBP-2 mRNAs in NK/DC and NK/M cultures upon rNP-LASV infection than in controls. The amount of soluble ULBP-1 in the supernatant of NK/APC during rWT-LASV or rNP-LASV infection was not different from that in mock cultures, as determined by ELISA (Fig. 5C ). There was significantly less soluble ULBP-1 in the supernatant of NK/M cultures when M were infected with rNP-LASV than with rWT-LASV. B7H6 mRNA was slightly but not significantly higher during rNP-LASV infection than under other conditions only in NK/M cultures (Fig. 5A) . The mRNA for BAT3/BAG6, another NKp30 ligand, was not modified after infection (data not shown). Thus, infection with a recombinant LASV that contains mutations affecting the exonuclease function of NP upregulates some NKG2D ligands at the surface of APC.
rNP-LASV-infected APC produce mRNAs encoding cytokines involved in NK cell activation. DC and M were infected with rWT-LASV, rNP-LASV, or a mock supernatant and cultured with or without NK cells. Total RNAs were extracted 24 h later, and mRNAs encoding cytokines involved in NK cell activation were assayed by quantitative RT-PCR. We found no significant modification of the levels of mRNAs encoding IL-12p35, IL12p40, IL-15, and IL-18 during rWT-LASV infection of DC or M (Fig. 6A) . In contrast, these mRNAs were more abundant in the rNP-infected DC and M cultures. Similarly, IL-12p35 and IL-15 mRNAs were significantly more abundant in all NK/APC cultures upon rNP-LASV infection than in controls. The mRNAs for IL12p40 and IL-18 were also more abundant when NK cells were added to rNP-LASV-infected M but were unaffected in the NK/DC cultures. Neither IL-12 nor IL-15 was detected in the supernatant of infected cultures (data not shown), and the amounts of IL-18 were similar in all samples (Fig. 6B) , indicating that these cytokines were not released in large amounts. These analyses show that infection by a recombinant LASV mutated within or nearby the exonuclease domain of NP leads to the transcription of the genes for IL-12p35, IL-12p40, IL-15, and IL-18 in DC and M.
DISCUSSION
The pathogenesis and the immune responses occurring during viral hemorrhagic fevers including LASV infection are still poorly understood. Nevertheless, the etiologic agents currently cause major public health problems in countries of endemicity, and some viruses are even emerging in new, populated areas (20) . The primary type I IFN response is inhibited in APC by LASV NP (7, 8) , suggesting that the overall immune response may be affected during the infection. Our work with an in vitro model previously showed that NK cells are activated by LASV-infected M but not by LASV-infected DC. However, these cells are not able to trigger effective cytotoxicity toward infected cells nor secrete IFN-␥ (15) . Here, we show that a recombinant LASV carrying two mutations affecting the exonuclease activity and IFN suppression of NP can mediate DC and M activation and functional NK responses. Importantly, DC were not inhibited after infection with this mutant, and the activation of M triggered by this mutant is greater than that with rWT-LASV infection. NK cells secreted IFN-␥ after stimulation by rNP-LASV-infected M, and NK cell cytotoxicity toward sensitive K562 cells and infected APC was increased. Cell contacts with APC are essential for NK cell activation and modulation of the repertoire of receptors, but soluble molecules, including cytokines secreted by APC, also seem to play a role. These observations confirm that the exonuclease function of LASV NP is essential for immune suppression and the inhibition of functional NK cell responses.
We show that NK cell activation is mediated by cellular contact with infected APC and soluble factors produced by these accessory cells. APC-mediated NK cell activation is well documented, and it involves activating receptor/ligand signaling pathways (18) . We show that rNP-LASV induces a change in the phenotype of infected APC: first, some NK cell-activating ligands are expressed at the surface of APC following rNP-LASV infection; then, the expression of several genes encoding cytokines important for NK cell activation is also modulated. In addition, we have also obpostinfection, and the expression of surface CD107a was determined by flow cytometry. NK cells were gated according to forward scatter/side scatter characteristics and expression of CD56. Representative dot plots for four independent experiments are shown. In addition, the percentages of positive cells from independent experiments (n ϭ 3 or 4) are displayed as dots, and mean values are indicated. (E) The expression of surface CD107a by NK cells cultured with DC or Mwas analyzed at 48 h postinfection by flow cytometry. The results are depicted as percentages of positive cells from independent experiments (n ϭ 5) displayed as dots, and means are indicated by horizontal bars. Statistical significance of differences was determined using Kruskal-Wallis followed by Dunn's test (A) or one-way ANOVA with a Bonferroni test (B, C, D, and E) (*, P Ͻ 0.05; ***, P Ͻ 0.001). The results reported are means and standard errors of the means of independent experiments (n ϭ 5 and n ϭ 7 for NK/DC and NK/M experiments, respectively). Statistical significance of differences was determined using one-way ANOVA followed by a Bonferroni post hoc test (* and #, P Ͻ 0.05; ** and ##, P Ͻ 0.01; ***, P Ͻ 0.001).
served that rNP-LASV-infected DC and M are activated in that costimulatory molecules are upregulated and cytokines and chemokines are released (35) . The NK cell activation that we report here is thus consistent with an activated phenotype of APC induced by rNP-LASV. The role of the interactions between APC and NK cells in the overall immune response including T cell immunity during rNP-LASV infection, however, has still to be determined.
Further illustration of the change in NK cell phenotype during rNP-LASV infection is the downregulation of CXCR3. This is likely due to desensitization of the receptor following the binding of CXCL9, CXCL10, and CXCL11; indeed, these chemokines are produced in large amounts during rNP-LASV infection (21) . This mechanism could trigger NK cell migration. NK cell depletion from the blood has been observed during LASV infection of nonhuman primates (22) and may be due to NK cell migration following CXCR3 downregulation. In vivo studies are needed to document this issue.
NKp30-and NKG2D-expressing NK cell populations decrease after rNP-LASV infection, and this phenomenon has been observed during NK cell activation (23, 24) and following activation by exogenous IL-2/phytohemagglutinin (PHA) (15) . NKp30 and NKG2D are cytotoxicity receptors involved in the recognition of target cells (25) . The downregulation of these two receptors at the surface of NK cells may be due to the binding of activating ligands followed by desensitization. Specifically, in response to activating stimuli, macrophages express various ligands of the activating receptor NKG2D, including ULBP-1, ULBP-2, ULBP-3, and MICA (24) . Consistent with this, we show that MICA/B are expressed at the surface of DC and M after rNP-LASV infection. Other NKG2D ligands such as ULBP molecules may also play a role. In accordance with these findings, prolonged exposure to its ligands downregulates NKG2D on NK cells (23) . We did not find any change in the expression of the published NKp30 ligands, BAT3 and B7-H6. Unfortunately, little is known about the identity of NKp30 ligands, and some as yet unidentified molecules may be involved during rNP-LASV infection. We believe that soluble ligands of activating NK cell receptors may play a role in desensitizing these receptors and more generally in the modulation of NK cell phenotype. Intracellular BAT3 can be released in exosomes by DC and bind to NKp30, thereby triggering NK cell functions (26) . Similarly, NKG2D ligands including ULBP molecules are shed in response to HIV-1 and inhibit NKG2D-mediated NK cell activation (27) . Further investigation of the expression of such soluble ligands of NK cell-activating receptors during LASV infection would be informative. Finally, the results of our study of rNP-LASV infection are consistent with published findings that activating ligands are produced by activated APC and mediate NK cell activation.
One of the most striking differences between NK cell activation mediated by rNP-LASV and that mediated by LASV is the ability of NK cells to lyse rNP-LASV-infected APC. Indeed, despite substantial acquisition of cytotoxic functions and lysis of K562 cells, NK cells failed to lyse LASV-infected M, which thus appear to be resistant to death mediated by activated NK cells. In contrast, NK cells efficiently degranulated toward rNP-LASV-infected APC, indicating that they are able to kill both DC and M during infection by rNP-LASV. This suggests that NK cells have acquired a more efficient cytotoxic phenotype and/or that rNP-LASV-infected APC are susceptible to NK cell-mediated cell death. Further work is required to characterize the mechanisms underlying these differences. Nevertheless, the exonuclease activity of LASV NP to affect substantially the functional properties of NK cells and/or to render infected cells resistant to NK cell-mediated cell death is probably a key event in immunosuppression during Lassa fever. Unfortunately, we were not able to detect any difference between The means and standard errors of the means of four to seven independent experiments are reported. Statistical significance of differences was determined using Kruskal-Wallis test followed by Dunn's post hoc test (*, P Ͻ 0.05; **, P Ͻ 0.01). hpi, hours postinfection. the titers of the supernatants of NK/APC cocultures and APC single cultures as NP-LASV replicates poorly in DC and M. However, we demonstrate that activated NK cells are fully functional and kill rNP-LASV-infected APC in the culture. Whether they may be involved in vivo to control the infection at an early step during rNP-LASV infection or after challenge with LASV has to be evaluated in further studies.
Functional NK cells also secrete IFN-␥. We show here that rNP-LASV induces substantial production of IFN-␥ in NK/M culture. In our model, IFN-␥ secretion can be modulated by the levels of type I IFN as described during lymphocytic choriomeningitis virus infection (28, 29) . Specifically, IFN-␥ production is regulated by a balance between STAT1 and STAT4 transcriptional pathways that are differentially activated according to the levels of IFN-␣/␤. NK cells express high levels of STAT4, driving IFN-␥ secretion in response to type I IFN, and STAT1 activation represses IFN-␥ production. Nothing is known about STAT1/ STAT4 regulation in NK cells during LASV infection. Further studies are needed to determine if, in our model, the expression of IFN-␥ by NK cells is modulated by the type I IFN response through these transcription factors. Other cytokines may play a role in IFN-␥ production: IL-12 and IL-18 are important mediators of IFN-␥ production (18, 30, 31) and are likely to be involved during rNP-LASV infection. We show that IL-12 and IL-18 mRNAs are produced in NK/APC cocultures during rNP-LASV infection and also that these cytokines themselves were not detectable in the supernatants. Possible explanations include a local secretion or a contact-dependent mechanism enabling NK cells to directly use these cytokines. Indeed, IL-12 can transit from DC to NK cells via synapses (30) . Such a mechanism may operate in our model although this remains to be demonstrated. Also, the role of IFN-␥ in the initiation of T cell responses during rNP-LASV infection remains unclear; we do not know whether IFN-␥ is produced in vivo during rNP-LASV infection. Further work on these issues may indicate whether rNP-LASV-activated NK cells could mediate protection against WT-LASV.
LASV and other arenaviruses suppress IFN production via a unique exonuclease activity of NP (7) (8) (9) . This function allows NP to digest viral dsRNA substrates generally sensed by retinoic acidinducible gene I (RIG-I). The mechanism leading to the inhibition of the primary type I IFN response during LASV infection is still unclear. As shown for lymphocytic choriomeningitis virus (32) , another Old World Arenavirus, this mechanism may involve the RIG-I/melanoma-differentiation-associated gene 5 (MDA5) pathway. We show that residues 389 and 392 in the active site of the exonuclease domain of NP or nearby strongly affect IFN production by APC (19) . Other investigators have confirmed that residue 389 is mandatory for functional exonuclease activity of NP (7, 9) . In addition to the inhibition of primary responses in LASV-infected cells, an early blockade of type I IFN production prevents subsequent transcription of IFN-stimulated genes (ISG), including some encoding mediators of NK cell activation. Our results here suggest that the lack of functional activity of NK cells observed during WT-LASV infection (15) is due at least partially to the inhibition of the type I IFN response via the enzymatic activity of LASV NP. The amounts of IFN-␣ and IFN-␤ may not be sufficient to induce fully activated APC and NK cells. In contrast, rNP-LASV-infected DC and M produce large amounts of type I IFN, thus driving NK cell activation. The role of these mediators in rNP-LASV infection should be investigated. Unfortunately, neutralizing antibodies directed against IFN-␣ and its receptor were insufficient to block the amounts of type I IFN present in our model (data not shown). Also various other investigative approaches are problematic with primary cells used as in our model. It is unlikely that the induction of NK cell responses directly results from a low replication of rNP-LASV in DC and M. In contrast to other studies (4, 7), we previously reported that rNP-LASV is stable but has a reduced minigenome activity, suggesting that residues D389 and G392 play a crucial role in viral infectivity and replication (19) . It has been shown that the lymphocytic choriomeningitis virus, an Old World Arenavirus, harboring a D382 substitution in NP (equivalent to 389 in LASV NP) grows to a slightly decreased level in IFN-deficient cells and is dramatically attenuated in IFN-competent cells (4) . Moreover, IFN-␣ has been shown to regulate LASV replication (33) . Together, these data suggest that the exonuclease activity upstream to the anti-IFN function of LASV NP is required for replication in APC, but we believe that it is mostly due to an indirect effect including a strong type I IFN response. NK cell responses will then result from rNP-LASV-induced APC activation.
A recent study showed that LASV and other arenavirus NPs inhibit the translocation and transcriptional activity of nuclear factor-B (NF-B) (34) . Moreover, the authors reported that recombinant lymphocytic choriomeningitis virus containing D382A and G385A substitutions (corresponding to 389 and 392 in LASV sequence, respectively) failed to inhibit NF-B activation. Such findings have to be demonstrated for LASV, but D389A and G392A substitutions in LASV NP are likely to be crucial in the inhibition of NF-B transcriptional activation. We believe that rNP-LASV may thus allow NF-B-triggered immune responses in our model. This explains the substantial amounts of inflammatory chemokines secreted by rNP-LASV-infected APC (21) .
In conclusion, we show here that residues 389 and 392 are involved in APC-mediated NK cell activation. Mutations at these positions affect NP function leading to the induction of immune responses. These findings thus confirm that the exonuclease activity of LASV NP is crucial in the inhibition of the immune response during LASV infection: it acts on APC with consequences for NK cell responses. As the infection with rNP-LASV leads to APC activation and NK cell responses presenting an activated phenotype and a full spectrum of functional properties, we would expect than T cell responses would similarly be boosted. This work provides new tools and suggests significant possibilities relevant to the immune response during LASV infection and viral hemorrhagic fevers generally. It also reveals potentially important clues about the mechanisms by which these viruses evade the immune system.
